Experimental therapy gantenerumab fails to slow or improve Alzheimer’s memory loss in clinical trials
Posted by admin
on Thursday, February 26, 2026 at 6:30 pm — No Comments | Leave a Comment
An experimental treatment, gantenerumab, failed to help people at high risk of memory loss from Alzheimer’s or those who were in the early phases of the disease, the manufacturer said Monday.